Conversely, a V203A point mutation disrupting TRAF1/cIAP2 interaction blocks TAK1 phosphorylation downstream of TLR4, inhibiting NF-κB/MAPK pathway activation and reducing joint inflammation in rheumatoid arthritis models (292). This evidence concerns the gene NFKB1 and Arthritis.